Literature DB >> 1516635

A possible role for urinary bladder epithelium in bradykinin-induced contraction in diabetic rats.

C Pinna1, O Caratozzolo, L Puglisi.   

Abstract

Diabetes provokes a greater responsiveness of rat urinary bladder preparations to bradykinin and a greater formation and release of prostaglandin F2 alpha, without affecting prostaglandin E2 release significantly. Inhibition of cyclooxygenase by indomethacin (1 microM) inhibits the contraction elicited by bradykinin and leads to identical contractile responses of control and diabetic urinary bladder strips. Removal of the urinary bladder epithelium does not modify the contractile response evoked by bradykinin in control preparations but significantly decreases the contraction of preparations of diabetic tissues. Quantitatively, the activity of control urinary bladder strips with epithelium and the activity of diabetic preparations without epithelium are the same. More prostaglandin F2 alpha is released into the medium by urinary bladder strips devoid of epithelium in both control and in diabetic rats. These results indicate a role for epithelial cells in the smooth muscle contraction evoked by bradykinin in diabetic rats.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1516635     DOI: 10.1016/0014-2999(92)90111-g

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  Urothelium-derived inhibitory factor(s) influences on detrusor muscle contractility in vitro.

Authors:  M H Hawthorn; C R Chapple; M Cock; R Chess-Williams
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

2.  Characterization of kinin receptors in human cultured detrusor smooth muscle cells.

Authors:  F Bellucci; P Cucchi; P Santicioli; M Lazzeri; D Turini; S Meini
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

3.  A pharmacological and histochemical study of hamster urethra and the role of urothelium.

Authors:  C Pinna; S Ventura; L Puglisi; G Burnstock
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

Review 4.  Non-adrenergic, non-cholinergic control of the urinary bladder.

Authors:  C H Hoyle
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

Review 5.  Modulation of lower urinary tract smooth muscle contraction and relaxation by the urothelium.

Authors:  Donna Sellers; Russ Chess-Williams; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-05-28       Impact factor: 3.000

6.  Effect of rilmakalim on detrusor contraction in the presence and absence of urothelium.

Authors:  Melinda Wuest; Susann Kaden; Oliver W Hakenberg; Manfred P Wirth; Ursula Ravens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-11-11       Impact factor: 3.000

Review 7.  Potential role of oxidative stress in the pathogenesis of diabetic bladder dysfunction.

Authors:  Qi-Xiang Song; Yi Sun; Kangli Deng; Jin-Yi Mei; Christopher J Chermansky; Margot S Damaser
Journal:  Nat Rev Urol       Date:  2022-08-16       Impact factor: 16.430

8.  Factors underlying the increased sensitivity to field stimulation of urinary bladder strips from streptozotocin-induced diabetic rats.

Authors:  T L Tammela; J A Briscoe; R M Levin; P A Longhurst
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

9.  Pharmacological analysis of the local and reflex responses to bradykinin on rat urinary bladder motility in vivo.

Authors:  A Lecci; S Giuliani; S Meini; C A Maggi
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

10.  β3 Relaxant Effect in Human Bladder Involves Cystathionine γ-Lyase-Derived Urothelial Hydrogen Sulfide.

Authors:  Emma Mitidieri; Annalisa Pecoraro; Erika Esposito; Vincenzo Brancaleone; Carlotta Turnaturi; Luigi Napolitano; Vincenzo Mirone; Ferdinando Fusco; Giuseppe Cirino; Raffaella Sorrentino; Giulia Russo; Annapina Russo; Roberta d'Emmanuele di Villa Bianca
Journal:  Antioxidants (Basel)       Date:  2022-07-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.